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Troponin-Tropomyosin: An Allosteric Switch or a Steric Blocker?
Andrea M. Resetar, Jacqueline M. Stephens, and Joseph M. Chalovich
Department of Biochemistry, Brody School of Medicine at East Carolina University, Greenville, North Carolina 27858-4354 USA

ABSTRACT The interaction of myosin subfragment 1 (S1) with actin-tropomyosin-troponin (regulated actin) is highly
nucleotide dependent. The binding of S1 or S1-ADP (but not S1-ATP nor N,N⬘--phenylenedimaleimide-modified S1-ATP) to
regulated actin activates ATP hydrolysis even in the absence of Ca2⫹. Investigations with S1 and S1-ADP have led to the idea
that some actin sites are directly blocked toward the binding of S1 either by tropomyosin or troponin. The blocked state is
thought to occur only at ionic strengths greater than 50 mM. The question is whether nonactivating S1 binding is blocked
under the same conditions. We show that troponin inhibits binding of the nonactivating state, N,N⬘--phenylenedimaleimideS1-ATP, to actin but only when tropomyosin is absent. A lag in the rate of binding of activating S1 to actin (an indicator of
the blocked state) occurs only in the presence of tropomyosin. Thus, tropomyosin inhibits binding of rigor S1 but not
S1-ATP-like states. No evidence for an ionic strength-dependent change in the mechanism of regulation was observed either
from measurements of the rate of activating S1 binding or from the equilibrium binding of nonactivating S1 to actin. At all
conditions examined, N,N⬘--phenylenedimaleimide-S1-ATP bound to regulated actin in the absence of Ca2⫹. These results
support the view of regulation in which tropomyosin movement is an allosteric switch that is modulated by activating myosin
binding but that does not function solely by regulating myosin binding.

INTRODUCTION
The actin-binding complex of tropomyosin and troponin
regulates skeletal and cardiac muscle contraction. Ca2⫹
binding to the troponin C (TnC1) component of troponin
causes rearrangements in the troponin complex (troponin I
(TnI), troponin T, and TnC) and changes the orientation of
tropomyosin on actin (Huxley, 1972; Haselgrove, 1972;
Parry and Squire, 1973; Kress et al., 1986; Lehman et al.,
1994, 2000; Vibert et al., 1997; Xu et al., 1999). In the
absence of Ca2⫹, the position of tropomyosin on actin is
such that it overlaps the putative binding site of rigor S1 but
not the putative binding site of S1-ATP (Vibert et al., 1997;
Xu et al., 1999; Craig and Lehman, 2001). Ca2⫹ causes
tropomyosin to move from the outer domain of actin toward
the inner domain where there is less potential overlap of the
rigor S1 binding site. High concentrations of rigor S1 stabilize tropomyosin into a third position (Vibert et al., 1997;
Poole et al., 1995) that may be associated with the highest
rate of ATP hydrolysis (Eisenberg and Kielley, 1970;
Bremel et al., 1972). Fluorescent probes placed on troponin I (Trybus and Taylor, 1980; Greene, 1986) and
tropomyosin (Ishii and Lehrer, 1990) support the idea that
there are at least three conformational states of regulated
actin. Probes on TnI I respond both to changes in Ca2⫹ and
to binding of “activating” cross-bridges to actin, whereas
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probes on tropomyosin respond primarily to binding of
activating cross-bridges.
An outstanding question is how the movement of tropomyosin on actin results in a large increase in ATPase
activity. Fig. 1 compares three potential mechanisms. In
the classic steric blocking hypothesis (Fig. 1 A) actin
exists in two states, one blocked toward myosin binding
and one open to myosin binding. The reduction in binding
of S1 to actin by tropomyosin directly results in a decrease
in ATPase activity.
Subsequent experimentation showed that binding of high
affinity or activating states to regulated actin was not totally
inhibited but exhibited positive cooperativity as the S1
concentration was increased (Greene and Eisenberg, 1980,
1988; Lehrer and Morris, 1982). Note that activating states
such as S1-ADP and rigor S1 can stabilize tropomyosin into
the active position, whereas nonactivating states such as
S1-ATP cannot (Chalovich et al., 1983; Brenner et al.,
1999). Furthermore, binding of nonactivating states such as
S1-ATP (Chalovich et al., 1981; Brenner et al., 1982),
N,N⬘--phenylenedimaleimide-S1-ATP
(PDM-S1-ATP
(Chalovich et al., 1983), and S1-ATP␥S (Resetar and Chalovich, 1995) are not greatly affected by Ca2⫹. Alternative
models were proposed in which Ca2⫹ and rigor type S1 are
allosteric effectors of tropomyosin (Chalovich et al., 1981;
Hill et al., 1981; Tobacman and Butters, 2000). In the Hill
model (Fig. 1 B), different states of bound tropomyosin
correspond to different levels of activity of actin in facilitating hydrolysis of ATP by myosin. Actin exists in two
major states. State 1 is less active, and state 2 is more active.
The binding of activating S1 stabilizes state 2. States 1 and
2 of actin have three substates depending on whether zero,
one, or two molecules of Ca2⫹ are bound per troponin
complex. Although tropomyosin inhibits the binding of
activating states of S1 (strong binding such as S1 and
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FIGURE 1 Models of binding of S1 to actin-tropomyosin-troponin. Actin is shown by ovals and tropomyosin by a solid bar. Unmodified S1-ATP
is shown by the shaded figures, whereas S1 modified by N-ethylmaleimide
is shown by the solid figures. (A) Classic steric blocking model. Ca2⫹
stabilizes the open state of the actin filament that is permissive for S1
binding. (B) Hill model of regulation. S1-ATP can bind to regulated actin
in the absence of Ca2⫹ even though the position of tropomyosin overlaps
the binding site of activating states of S1 such as S1-ADP and rigor S1.
This is state 1(0). Ca2⫹ changes the position of tropomyosin to stabilize
actin in state 1(2) where the subscript refers to the number of Ca2⫹ bound
per troponin. The ATPase rate is much higher in the presence of saturating
Ca2⫹ but is not maximal. Binding of rigor type S1 (solid S1 shape) to actin
causes yet another change in tropomyosin position to form the state 2. For
clarity, the rigor S1 is not shown bound to the actin filament. In state 2 the
affinity of activating forms of S1 is higher, but there is little change in
S1-ATP affinity. Actin is most active in accelerating ATP hydrolysis in
state 2 regardless of the number of Ca2⫹ bound per troponin. (C) McKillop
and Geeves model. Ca2⫹ stabilizes the closed state of the actin filament
that is permissive for low affinity S1 binding. Occupancy of the actin
filament with rigor type S1 stabilizes the open state. S1 bound in the open
state can isomerize to a more stable complex. Force can be generated only
when actin is in the open state.

S1-ADP) to actin there is little effect on the binding of
nonactivating states (weak binding such as S1-ATP, and
S1-adenosine 5⬘-(␥-thiotriphosphate) (S1-ATP␥S)). Activation results from acceleration of the rate of transition from
a bound S1 complex with low ATPase activity to a bound
complex with high ATPase activity.
The Hill model had an apparent discrepancy between the
predicted effects of Ca2⫹ on the equilibrium binding of S1
to regulated actin and the kinetics of binding (Trybus and
Taylor; 1980; McKillop and Geeves, 1993). To overcome
this discrepancy, the Hill model was revised with the
inclusion of a blocked state to which S1 could not bind
(McKillop and Geeves, 1993). The McKillop and Geeves
model (Fig. 1 C) retains elements of the two earlier models.
In the absence of Ca2⫹, 80% of the sites of regulated actin
are thought to be blocked or unavailable for binding to rigor
S1 (McKillop and Geeves, 1993). Some researchers have
Biophysical Journal 83(2) 1039 –1049
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suggested that blocking of binding may be due to troponin
rather than tropomyosin. This blocked state was thought to
be destabilized below 50 mM ionic strength (Head et al.,
1995). The loss of the blocked state at low ionic strength
and the assumption that only a fraction of actin sites were
blocked was used to explain the earlier observations that
S1-ATP-like state binding to regulated actin was unaffected
by Ca2⫹. Binding of Ca2⫹ to troponin shifts the equilibrium
from the blocked state to a closed state that permits binding
but not acceleration of ATPase activity. Binding of activating states of S1 causes formation of an open state that
activates ATP hydrolysis and force production. Presumably
substates exist in this model also, and the properties of the
closed and open states change depending on the number
Ca2⫹ bound to TnC. Activation results from unblocking the
binding of myosin to actin and also by a change in the rate
of transition between bound states.
The Hill model can predict the effects of Ca2⫹ on steadystate ATP hydrolysis both at the limits of saturating actin
and saturating S1 (Hill et al., 1981). It is unclear if the
McKillop and Geeves model can make similar predictions
because that model has not been extended beyond binding
to ATPase activities. Because of the success of the Hill
model in simulating the regulation of ATPase activity we
have reexamined some of the apparent discrepancies of that
model. For example, we recently showed that the Hill model
does correctly predict the binding kinetics of the S1-actin
interaction (Chen et al., 2001). We have now taken another
look at the possibility that the binding of nonactivating
states of S1 may be blocked under some conditions. We
examined the effect of tropomyosin-troponin, troponin
alone, and TnI on the binding of PDM-S1-ATP, S1, and
S1-ADP to actin. PDM-S1-ATP was used as a model of a
nonactivating state because its low ATPase activity permitted binding to be measured at high concentrations of modified S1. The binding constant of PDM-S1-ATP to actin is
only approximately twofold stronger than that of S1-ATP
but 0.001 of that of the binding of S1-ADP to actin (Chalovich et al., 1983; Greene et al., 1986; Kirshenbaum et al.,
1993). In the presence of ATP, PDM-S1 does not activate
the regulated filament in the absence of Ca2⫹ (Greene et al.,
1986).
Our results do not support the hypothesis that the binding
of nonactivating states of S1 to regulated actin is blocked.
We also have failed to find convincing evidence for a
change in mechanism of regulation as the ionic strength is
lowered below 50 mM. We suggest that the Hill model is a
reasonable description of regulation of striated muscle contraction. The primary function of the change in tropomyosin
binding to actin is to alter the ability of actin to act as a
cofactor in ATP hydrolysis. In terms of regulation it may be
more important that myosin affects tropomyosin binding
than tropomyosin affects myosin binding.
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state that was blocked toward the binding of S1-ATP-like states, binding
was simulated by the following model:

Materials
[␥⫺32P] ATP was obtained from New England Nuclear (Wilmington, DE)
and [1,4-14C] maleic anhydride was from Amersham Pharmacia Biotech
(Piscataway, NJ). N-((2-(iodoacetoxy)ethyl)-N-methyl)amino-7-nitrobenz2-oxa-1,3-diazole (IANBD) was obtained from Molecular Probes (Eugene,
OR), and ATP from Sigma (St. Louis, MO). All other chemicals were
reagent grade. [14C]- PDM, synthesized as described by Wells and
Yount (1982), and PDM from Aldrich (Milwaukee, WI) were purified by
sublimation.

Protein preparations
Skeletal muscle actin (Spudich and Watt, 1971) and myosin (Kielley and
Harrington, 1960) were isolated from rabbit back and leg muscles. Myosin
subfragment 1, S1, was prepared by digestion of myosin with chymotrypsin (Weeds and Taylor, 1975). S1 was modified with PDM as described
elsewhere (Wells and Yount, 1982). Contaminating unmodified S1 was
removed by sedimentation in the presence of actin (Chalovich et al., 1983).
Troponin and tropomyosin were prepared using hydroxyapatite chromatography (Eisenberg and Kielley, 1974). Troponin was labeled with
IANBD as described by Trybus and Taylor (1980). TnI was isolated from
the pure troponin complex (Potter, 1982).
Protein concentrations were determined by ultraviolet absorption at 280
nm and the extinction coefficients used were 750 cm2/g for S1, 1150 cm2/g
for F-actin, 290 cm2/g for tropomyosin, 450 cm2/g for troponin, 380 cm2/g
for the troponin-tropomyosin complex, and 397 for TnI. For determination
of molar concentrations, the following molecular weights were used: S1,
120,000; actin, 42,000; tropomyosin, 68,000; troponin, 80,000; the troponin-tropomyosin complex, 150,000; and TnI, 21,000.

B % C;
C ⫹ M % CM;

K1 ⫽ 关C兴/关B兴
K2 ⫽ 关CM兴/关C兴 ⫻ 关M兴

in which B and C are the blocked and closed forms of actin, respectively,
and M is myosin with equilibrium constants as shown. In the McKillop and
Geeves model, the open state is not populated in the absence of Ca2⫹ so it
was not included in this analysis. The total actin concentration, AT ⫽ B ⫹
C ⫹ CM, and the total myosin concentration is represented by MT. The
parameter of interest is , which is the fraction of actin sites occupied by
myosin or [CM]/[A].  can be written in terms of AT and MT as shown in
Eq. 3.

 ⫽ 1/共2 ⫻ K1 ⫻ K2兲 ⫻ 共1 ⫹ K1 ⫹ AT ⫻ K1 ⫻ K2 ⫹ K1
⫻ K2 ⫻ MT ⫺ Sqrt关共⫺4 ⫻ AT ⫻ K1∧2 ⫻ K2∧2
⫻ MT兲 ⫹ 共⫺1 ⫺ K1 ⫺ AT ⫻ K1 ⫻ K2 ⫺ K1 ⫻ K2
⫻ MT兲∧2兴兲/AT
To simulate the case where there was no blocked state, K1 was set to 100.
In the case where 80% of the actin was assumed to be in the blocked state,
K1 was set to 0.25. The value of K2 was allowed to float to obtain the best
fit of Eq. 3 to the data sets.

Stopped flow kinetic studies
Equilibrium binding assays
Binding assays were done either with PDM-S1 or with 14C-PDM-S1.
Mixtures of PDM-S1, actin, and various combinations of tropomyosin,
troponin, or troponin subunits were centrifuged at 135,000 ⫻ g for 25 min
to separate free PDMS1 from actin-bound PDMS1. ATP was present in
all binding assays to insure that the S1 was in the nonactivating or “weak
binding” state (Greene et al., 1986). In studies with unlabeled PDMS1,
pellets were suspended in sodium dodecyl sulfate-sample buffer and the
proteins were separated by 10% polyacrylamide-sodium dodecyl sulfate
electrophoresis. Gels were stained with Coomassie Blue, and protein bands
were analyzed by densitometry with a Hewlett Packard Scanner Jet iicx/t
(Palo Alto, CA) and IMAGE Quant software (Molecular Dynamics,
Sunnyvale, CA). In the case of 14C-labeled S1, aliquots of the supernatant
were analyzed in a scintillation counter and compared with the total counts
present before centrifugation to determine the fraction bound to actin. In all
cases, the amount of PDMS1-ATP binding to actin was corrected for the
sedimentation of PDMS1-ATP in the absence of any actin. This was
typically less than 4% of the total PDMS1-ATP concentration.
Because PDM-S1 remains in a purely nonactivating state only in the
presence of ATP (Greene et al., 1986), it was important to insure that ATP
was not depleted during the binding measurement. The ATPase activity of
every PDMS1 preparation was measured, and the concentrations of
PDM-S1 and ATP present in the assays were adjusted to insure that
sufficient ATP remained to maintain a nonactivating state. The PDMS1
preparations had ATPase activities ⬍1% that of unmodified S1. In some
experiments 32P-ATP was included in the binding assay so that the amount
of ATP remaining could be measured directly.
Binding data were analyzed using the MLAB modeling program (Civilized Software, Bethesda, MD) or Mathematica (Wolfram Research, Inc.,
Champaign, IL). To examine the possible existence of a regulated actin

Measurements were made with an Applied Photophysics DX17.MV/2
sequential stopped flow spectrofluorometer (Leatherhead, UK). The binding of S1 to actin was done with light scattering using excitation at 460 nm
and measuring emission through a 455-nm-long pass filter. Activation of
thin filaments by S1 or S1-nucleotides in the absence of Ca2⫹ was monitored as a decrease in IANBD fluorescence with a filter having 0%
transmittance at 510 nm and 80% transmission at 540 nm using excitation
at 492 nm. Averages of at least three traces were analyzed with the
software provided in the Applied Photophysics package. The averaging
improved the signal to noise ratio but did not change the shape of the
curves because the curves in a single experiment were very similar to each
other. In some experiments a lag preceded the exponential phase of
binding. The lag duration was first estimated by eye. An exponential
function was fitted to that part of the curve between 1.5 times the estimated
lag duration to the end of the reaction. The lag was then defined by the
intersection of the fitted curve with the abscissa or time axis. The observed
changes were far greater than the variations in estimating lag durations.

ATPase assays
Unmodified S1 was used to determine the effect of regulatory components
on the actin-activated ATPase rate. Hydrolysis of ATP by was measured by
the liberation of 32Pi from [␥-32P]-ATP as described previously (Chock and
Eisenberg, 1979). In cases where the concentration of S1 was very high a
slight modification to the ATPase assay was made to improve extraction of
32
Pi (Hemric et al., 1993). Aliquots were removed at four times during the
reaction to determine the initial velocity of the reaction. In experiments
where a protein component was varied the solution was maintained at
constant ionic strength.
Biophysical Journal 83(2) 1039 –1049
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FIGURE 2 Effect of whole troponin and troponin-tropomyosin on the
ATPase activity of S1 (squares) and on the binding of PDM S1 to actin
(circles). Conditions: 25°C, 20 M actin, 1.6 M pPDM-S1-ATP, or 0.1
M unmodified S1 in a buffer containing 1 mM ATP, 3 mM MgCl2, 10
mM imidazole, 0.5 mM EGTA, and 1 mM dithiothreitol. (A) Absence of
tropomyosin. The fraction of PDM-S1-ATP bound in the absence of
troponin was ⬇35%. The ATPase activity in the absence of troponin was
⬇4 s⫺1. All other data are expressed as the fraction of these values
measured in the absence of troponin. The dotted lines are the 95% confidence limits of the binding. (B) Presence of tropomyosin; conditions same
as in A. The ATPase rate in the absence of troponin and presence of
tropomyosin was ⬇2.3 s⫺1. The 95% confidence intervals for both sets of
data are shown by dotted curves.

RESULTS
We first wished to determine if individual components of
the troponin complex could inhibit the binding of myosinATP-like states to actin. That is, could a modified steric
blocking model exist in which the blocked state (Fig. 1, A
and C) resulted from troponin itself inhibiting myosin binding? Fig. 2 A shows that troponin alone (no tropomyosin)
inhibits the binding of 14C-labeled PDM-S1-ATP (circles)
to actin at low ionic strength. The actin-activated ATPase
activity of S1 decreased in parallel with the inhibition of S1
binding.
Tropomyosin completely restored the binding of PDMS1-ATP to actin even in the presence of excess troponin
(Fig. 2 B) but did not restore the ATPase activity. In fact,
less troponin was required to inhibit the ATPase activity in
the presence of tropomyosin. This result is consistent with
the idea that troponin acts by influencing the position of
tropomyosin rather than by producing an inhibitory effect
that is amplified by tropomyosin.
Fig. 3 shows the effect of troponin I on the binding of
PDM-S1-ATP to actin-tropomyosin (circles) and on the
ATPase activity (squares). Because pure troponin I is insoluble at low ionic strength the study was limited to the case
where a saturating concentration of tropomyosin was
Biophysical Journal 83(2) 1039 –1049
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FIGURE 3 Effect of TnI on the ATPase activity of S1 (squares) and on
the binding of PDM S1 to actin-tropomyosin (circles). Note that the
affinities of PDM-S1 and unmodified S1 are similar in the presence of
ATP (see Fig. 8). The conditions are the same as in Fig. 2. In all cases the
concentrations of actin and tropomyosin were 20 and 4.3 M, respectively.
The 95% confidence limits for the data are shown by dotted lines.

present. As with whole troponin the inhibition of ATPase
activity was maximal under conditions where there was
little inhibition of binding of PDM-S1-ATP to actin. The
pattern of Fig. 3 resembles that of Fig. 2 B in that tropomyosin permits inhibition of ATPase activity while diminishing the effect on S1 binding.
Another measure of a blocked state is the appearance of
a lag in the rate of binding of rigor S1 to actin. Because
whole troponin exhibited blocking activity in the absence of
tropomyosin we determined the effect of troponin on the
kinetics of rigor S1 binding to actin. Light scattering was
measured to follow the rate of binding at 170 mM ionic
strength in the absence of Ca2⫹. Examples of time courses
for the binding of an excess of S1 to pure actin, actintropomyosin-troponin, and actin-tropomyosin-TnI are
shown in Fig. 4 A. The binding of S1 to pure actin occurred
with a simple time course (curve a). We observed a lag in
the presence of tropomyosin-TnI (b) but with a smaller
duration than obtained with tropomyosin-troponin (curve c).
The effect of tropomyosin-TnI on S1 binding was slightly
less than reported by Geeves et al. (2000). However, we
reached the same conclusion that troponin I acts to stabilize
tropomyosin in an inhibited state. We also noted that a high
concentration of troponin, in the absence of tropomyosin,
reduced the rate of binding slightly but did not produce a lag
(data not shown). Whereas inhibition of binding of PDMS1-ATP occurred with troponin only in the absence of
tropomyosin, inhibition of the rate of binding of rigor S1
occurred with troponin only in the presence of tropomyosin.
Therefore, an observation of regulation of the rate of rigor
S1 binding does not imply that the binding of S1-ATP-like
states will be blocked.
Fig. 4 B shows the duration of the lag as a function of the
concentration of TnI at saturating tropomyosin, whole tro-
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FIGURE 4 Time course of light scattering changes as S1 binds to
actin-tropomyosin. (A) Binding of 8 M S1 to 1 M actin-tropomyosin
(curve a), to 1 M actin-tropomyosin-TnI (curve b), and to 1 M actintropomyosin-troponin (curve c) at 25°C in a buffer containing 145 mM
KCl, 20 mM imidazole, 3 mM MgCl2, 2 mM EGTA, 1 mM dithiothreitol,
pH 7.0. Curves b and c are sigmoidal having lags at the initial part of the
time course. (B) Magnitude of the lag for binding of S1 to actin in the
presence of varied TnI and 0.214 M tropomyosin (circles), varied troponin, and 0.214 M tropomyosin (triangles) or varied troponin-tropomyosin
(squares).

ponin at saturating tropomyosin, and variable concentrations of the tropomyosin-troponin complex. Increasing the
concentration of either TnI (triangles) or troponin (circles)
at a fixed saturating tropomyosin concentration produced a
hyperbolic increase in the lag duration. The effects of TnItropomyosin and troponin-tropomyosin were similar. In another experiment, the concentrations of both troponin and
tropomyosin were varied together (squares). In this case, no
lag was seen until more than 1 troponin-tropomyosin complex was added per 7 actin monomers. At that point there
was a sharp increase in the duration of the lag. These results
are consistent with models in which tropomyosin is a cooperative switch that impedes the binding of S1 and that
troponin or TnI stabilize the tropomyosin in the inactive
state. This is the more common view. The data shown here
do not support models in which troponin blocks actin binding sites, whereas tropomyosin affects isomerization rates
between attached states.

1043

FIGURE 5 Effect of ionic strength on the rate of S1 binding to regulated
actin. Binding was measured by light scattering in the presence and
absence of Ca2⫹ at 25°C. Conditions: 10 mM imidazole, pH 7.0, 2 mM
MgCl2, 2 mM EGTA or 0.2 mM CaCl2, 0 or 5 mM MgADP, 1 M actin,
0.25 M troponin-tropomyosin, and 8 M S1. Ionic strength was varied
from 30 to 320 mM with KCl. (A) S1-ADP binding at 50 mM ionic strength
in the presence and absence (bold line with a lag) of Ca2⫹. A single
exponential function accurately describes the major part of the curve
obtained in the absence of Ca2⫹ (dashed line). Intercept of the dashed line
with the abscissa defines the lag. The inset shows the residuals (experimental curve, fitted line) for the data in the absence of Ca2⫹. (B) Lag
duration versus ionic strength for S1-ADP in the absence of Ca2⫹. The
curve through the data is arbitrary. (C) Binding of rigor S1 at 270 mM ionic
strength in the presence or absence (bold line) of Ca2⫹. The extrapolated
dashed line from the exponential fit to the curve defines the lag. The inset
shows the residuals for the data in the absence of Ca2⫹. (D) Lag duration
versus ionic strength for rigor S1 in the absence of Ca2⫹. The solid curve
is not a fit to the data.

The results presented thus far show that regulation of the
rate of rigor S1 binding does not act as a predictor of the
effect on the equilibrium binding of S1-ATP-like states. We
next explored the possibility that blocking of activating S1
binding occurs only above 50 mM ionic strength and that
the binding of PDM-S1-ATP is blocked under the same
conditions. We measured the lag in binding over a wide
range of ionic strength conditions in both the presence of
ADP and in rigor to help us identify the conditions where a
blocked state is possible. Binding was assessed as an increase in light scattering after rapid mixing of S1 or S1ADP and regulated actin in a stopped flow device (Fig. 5).
In the presence of ADP and at 50 mM ionic strength a lag
of 35 to 50 ms was evident in the absence of Ca2⫹. No lag
was observed in the presence of Ca2⫹ (Fig. 5 A). At ionic
strengths below 50 mM, the lag became very small (Fig. 5
B). An expanded view of the ionic strength dependence of
the lag duration is shown in the inset to Fig. 5 B. Below 30
mM ionic strength the lag was undetectable. Above 150 mM
ionic strength, the duration of the lag increased greatly with
increases in salt concentration. It was unclear if a real
plateau was reached at 300 mM ionic strength.
Biophysical Journal 83(2) 1039 –1049
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The extended lag at high ionic strength could have resulted from a change in the affinity of S1 for ADP with
increasing ionic strength. This artifact was ruled out by
repeating the experiment in the absence of nucleotide (Fig.
5, C and D). The duration of the lag was much smaller in the
case of rigor binding. No appreciable lag was observed
below 120 mM ionic strength. As the ionic strength was
increased above 120 mM, the duration of the lag increased
as it had done in the presence of ADP (Fig. 5 D). These
results do not support the idea that the mechanism of regulation changed at 50 mM ionic strength. Rather, there was
a continuous change in lag over the entire range of conditions examined and the point at which a lag could first be
observed depended on the nucleotide bound to S1. We do
concur with others that there is a minimal ionic strength at
which a lag is observed. A measurable the lag was observed
above 30 mM ionic strength in the presence of ADP. If the
binding of S1-ATP-like states is blocked under any conditions it is likely that they are blocked above 30 mM ionic
strength.
The binding of PDM-S1-ATP to actin-tropomyosin-troponin was measured at 25, 60, and 100 mM ionic strength
conditions. S1 modified with PDM was used to reduce the
rate of ATP hydrolysis so that S1 would remain in an ATP
bound state throughout the binding assay. At 25 mM ionic
strength it was possible to obtain 80% saturation of the actin
filament with PDM-S1-ATP (Fig. 6 A). The binding curve
was hyperbolic with a fitted endpoint of 1 PDM-S1-ATP
bound per actin monomer. At 60 mM ionic strength (Fig. 5
B), 60% saturation was reached in the absence of Ca2⫹
(open symbols) and the fitted endpoint was 1.0. Binding
was also measured in the presence of saturating Ca2⫹ (solid
symbols). There was no significant Ca2⫹-dependence to the
binding. Note that binding in the presence of Ca2⫹ was
limited to lower PDM-S1 concentrations because ATP was
depleted at higher concentrations due to residual ATPase
that was Ca2⫹ sensitive.
The binding data obtained in the absence of Ca2⫹ could
be fitted equally well with a simple binding isotherm and
with a model that incorporates a rapid equilibrium between
a blocked state (80%) and a closed state (Eq. 3). However,
this model leads to the conclusion that Ca2⫹ weakens the
binding of S1 to regulated actin (see Discussion).
Binding was difficult to measure at 100 mM ionic
strength because of the low affinity under that condition
(Fig. 6 C). 14C-PDM-labeled S1 was used in this experiment to facilitate measurement of the low fraction of binding. The highest reliable measured fraction of saturation was
0.4, and the fitted endpoint was 1.0. If 80% of the actin sites
were blocked toward the binding of PDM-S1-ATP and the
blocked state were stable, one would expect to observe a
maximal degree of saturation of 0.2 (dotted curve). This is
not the case. If the blocked state were in rapid equilibrium
with a nonblocked state (the closed state) then the degree of
saturation would appear unchanged but the overall affinity
Biophysical Journal 83(2) 1039 –1049
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FIGURE 6 Binding of PDMS1-ATP to regulated actin. Reaction conditions: 10 mM imidazole, pH 7.0, 2 mM MgCl2, 2 mM EGTA or 0.2 mM
CaCl2, and 1.6 mM MgATP (25 mM ionic strength studies) or 7.5 mM
MgATP (60 and 100 mM ionic strength studies). Ionic strength was
adjusted with potassium propionate because propionate salts are less disruptive of protein-protein interactions than chloride salts. Different symbols indicate different protein preparations. (A) 25 mM ionic strength. The
binding constant is 21,000 M⫺1. (B) 60 mM ionic strength. Binding in the
absence (open symbols) or presence (closed circles) of calcium. The solid
curve is a simulation using Eq. 3. If the blocked state was assumed to be
virtually unpopulated K2 ⫽ 6700 M⫺1 but if 80% of the actin was assumed
to be in the blocked state K2 increased to 33,600 M⫺1. (C) Binding at 100
mM ionic strength was measured using both 14C PDM (circles) and
unlabeled PDM (squares). Fitting the data without a blocked state gave an
affinity, K2 ⫽ 2300 M⫺1. Assuming that 80% of the sites were blocked the
value of K2 became 11,000 M⫺1. The dotted curve is the best fit to the data
assuming that 80% of the sites are stably blocked (see text). The insets
show the residuals for the respective binding data and a model with a single
binding site with a stoichiometry of 1 S1 per actin monomer. The ordinates
of the insets are ⫾0.4.

would be reduced. We will show later that the measured
affinity is equal to that for actin in the absence of regulatory
proteins; that is the binding curve is consistent with the
absence of a blocked state.
Conclusions drawn from Fig. 6 are valid only if the actin
filament did not become activated as a result of binding of
large amounts of PDM-S1. Several experiments were done
to test for activation during PDM-S1 binding. One char-
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TABLE 1 Rate of ATP hydrolysis by PDMS1 at  ⴝ 60 mM
ionic strength
[PDMS1], M

ATPase Rate, s⫺1

EGTA or Ca2⫹

27
82
188
82

0.118
0.087
0.082
0.857

EGTA
EGTA
EGTA
Ca⫹⫹

acteristic of activation of regulated actin is that the rate of
ATP hydrolysis per unit S1 increases with the concentration
of S1 so that the rate approaches that observed in the
presence of Ca2⫹. Table 1 shows that from 27 to 188 M
PDM-S1-ATP, the ATPase rates were constant and
roughly 10% of the rate in the presence of Ca2⫹.
Activation of regulated actin can also be seen as an
increase in both the affinity and rate of binding of S1 to
actin as the occupancy of actin with S1 is increased. An
example of the change in the rate of binding is a lag in
binding as shown in Figs. 4 and 5. Fig. 7 A shows the time
course of light scattering as S1 binds to actin in the absence
of Ca2⫹. In the case of unmodified S1 (curve a), there was
a large and rapid increase in light scattering that reached
equilibrium within 200 ms as the S1 bound to the regulated

actin. This curve establishes the maximum expected extent
of S1 binding. In the case of PDMS1 with no added ATP
(curve b), there was slow increase in light scattering indicating that as the bound nucleotide was released from the
PDM-S1 the binding became tighter and the actin filament
became activated. In the presence of either 1 or 7.5 mM
ATP there was no evidence for an increase in binding over
the course of 1000 s.
Activation of the actin filament can also be shown by a
decrease in the fluorescence of an NBD probe on troponin
I (Trybus and Taylor, 1980; Greene, 1986). Fig. 7 B shows
that the binding of unmodified S1 to regulated actin resulted
in a very rapid decrease in fluorescence (curve a). PDMS1
binding resulted in a slow decrease in fluorescence (curve
b). The slow rate may be due to the rate of release of
nucleotide bound to the PDM-S1. In the presence of either
1 or 7.5 mM ATP (curves c and d) there was no evidence of
a fluorescence change over the course of 1000 s. As a
further test, PDMS1 was preincubated with 1 mM ATP for
1 h to promote ATP hydrolysis before being assayed in the
stopped flow. Even with the longer exposure of ATP to
PDM-S1, there was no evidence of activation of the actin
filament (data not shown). These results confirm that under
the conditions of our binding studies the actin filament was
not activated.
DISCUSSION

FIGURE 7 Time course of binding of S1, PDMS1, or PDMS1-ATP to
regulated actin at 100 mM ionic strength, 20°C. Reaction conditions were
10 mM imidazole, 2 mM MgCl2, 2 mM EGTA, and 10 M actin, 2.5 M
troponin-tropomyosin, and 40 M S1 or 100 M PDMS1. MgATP
concentrations ranged from 0 to 7.5 mM. Ionic strength was adjusted with
KCl. (A) Light scattering traces for binding of S1 (a), PDMS1 (b),
PDMS1 with 1 mM (c) or 7.5 mM MgATP (d). (B) Changes in IANBDTnI fluorescence upon the binding of S1 (a), PDMS1 (b), and PDMS1
with 1 mM (c), or 7.5 mM (d) MgATP.

Fig. 1 B illustrates the model of regulation of contraction
that we favor. In this model tropomyosin is an allosteric
switch that responds to Ca2⫹ and rigor S1 to control the
pathway of ATP hydrolysis (Hill et al., 1980, 1981; see Fig.
1 B). The Hill model correctly predicts the kinetics of ATP
hydrolysis. It is unclear that other models can simulate the
steady-state kinetics of ATP hydrolysis both with an excess
of actin and with an excess of S1. The Hill model also
incorporates the observed nucleotide-dependent difference
in the binding of S1 to regulated actin. In particular, tropomyosin-troponin does not greatly inhibit the binding of
S1-ATP and S1-ADP-Pi to actin even in the absence of
Ca2⫹ (Chalovich et al., 1981; Chalovich and Eisenberg,
1982). In terms of the model, nonactivating myosin can bind
to actin even when tropomyosin is in the fully inhibitory
position with no bound Ca2⫹ (state 1(0)).
Another feature of the Hill model is that there is no
assumption that the catalytic activity of pure actin is equal
to that of the actin-tropomyosin-troponin complex. This
provides the possibility of explaining how the ATPase rate
in the presence of regulatory proteins can exceed that obtained with pure actin (Bremel et al., 1972). That is, an
increase in Ca2⫹ favors state 1(2) over state 1(0) and increases the ATPase activity to a submaximal level. Note that
in Fig. 1, B and C, all of possible substates of Ca2⫹ bound
to troponin are not shown. The maximal rate of ATP hydrolysis occurs when rigor-type myosin (shown in black in
Biophysical Journal 83(2) 1039 –1049
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Fig. 1) binds to actin and stabilizes actin in state 2. The
ATPase rate in state 2 may be higher than that observed in
the absence of regulatory proteins because the regulatory
proteins stabilize state 2 in these conditions. Activating S1
(S1-ADP and rigor S1) binds tighter to actin-tropomyosintroponin that is in state 2, thus stabilizing state 2. In this
model the change in affinity of strong binding or activating
or rigor type S1 is important in altering the state of activity
of actin. This gives rise to a different pathway where ATP
hydrolysis is more rapid. That is, whereas the increase in
activating myosin binding is part of the activating signal, it
is the change in the pathway of hydrolysis that causes the
large increase in ATPase rate.
Several shortcomings of the Hill model have been reported, and we have reexamined various aspects of the
model. For example, although the Hill model explained the
effect of Ca2⫹ on the equilibrium binding of S1 to regulated
actin, there appeared to be a discrepancy with the Ca2⫹
effect on the rate of binding (Trybus and Taylor, 1980;
McKillop and Geeves, 1993). We have recently shown that
the Hill model does predict the correct kinetics of binding
(Chen et al., 2001). The suggestion was also made that steric
blocking occurs only above 50 mM ionic strength and that
only a fraction of the potential myosin binding sites are
blocked (Head et al., 1995). Furthermore, the observation
that fluorescent probes on troponin are sensitive to changes
in Ca2⫹ and activating S1 binding whereas probes on tropomyosin are sensitive only to S1 binding (Ishii and Lehrer,
1990) caused some to speculate that troponin might be
responsible for covering the myosin binding site on actin.
These later suggestions caused us to reevaluate the possible
blocking of nonactivating S1 states at higher ionic strengths
and under conditions where blocking of 80% of the sites
could be detected. We also examined the possibility that
troponin blocked the binding of S1 to actin-tropomyosin.
We examined the possibility that whole troponin or the
TnI component of troponin might inhibit the binding of S1
to actin. Isolated troponin I inhibits actin activation of
ATPase activity but only when bound to actin in a 1:1 ratio
(Wilkinson et al., 1972; Perry et al., 1972). Our present data
indicate that whole troponin does inhibit the binding of
PDM-S1-ATP to actin in the absence of tropomyosin. The
inhibition of ATPase activity is roughly correlated with the
inhibition of S1 binding. However, in the presence of saturating tropomyosin, troponin and TnI have very little effect
on the binding of PDM-S1-ATP to actin although the
ATPase activity is markedly inhibited.
Troponin binds less tightly to pure actin than to actintropomyosin at moderate and high ionic strength (Potter and
Gergely, 1974; Hitchcock, 1975). However, at low ionic
strength, such as that used in Fig. 2, tropomyosin has less
effect on the affinity of troponin to actin (Hitchcock, 1975).
It is possible that at the highest concentrations of troponin
used in Figs. 1 and 2 that the amount of troponin and TnI
bound to actin may exceed the normal 1:7 ratio (Hitchcock,
Biophysical Journal 83(2) 1039 –1049
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1975). In the presence of tropomyosin, an amount of troponin or TnI sufficient to reduce the ATPase activity to less
than 15% of the initial value has virtually no effect on the
binding of PDM-S1-ATP to actin. A concentration of
whole troponin that is 6.5 times the concentration required
to give 50% inhibition of ATPase activity reduced the
fraction of PDM-S1-ATP bound to actin by only 2%.
Regardless of possible effects of having an excess troponin
bound to the actin-tropomyosin the binding of S1-ATP-like
states to actin was not inhibited, but the ATPase activity was
inhibited normally. This can only mean that as long as
tropomyosin is present (as in the normal physiological case)
neither troponin nor tropomyosin inhibit nonactivating S1
binding to actin. This result is consistent with earlier studies
reviewed elsewhere (Chalovich, 1992).
The commonly held view is that troponin acts indirectly
by modulating the binding of tropomyosin to actin (e.g.,
Geeves et al., 2000); the data of Fig. 3 B support that view.
When actin was titrated with tropomyosin-troponin no lag
occurred until a nearly saturating amount of the tropomyosin-troponin complex was added. If the amount of tropomyosin added to actin was constant a lag was seen even
with subsaturating amounts of troponin or TnI. Troponin
either induced the binding of tropomyosin to actin or it
stabilized tropomyosin in an inhibitory state. In either case
the tropomyosin component of the regulatory complex is
responsible for the inhibition of binding of activating S1 to
actin.
The other concern that we addressed is whether the
binding of nonactivating type S1 states to actin is blocked
under conditions that a blocked state is supposed to exist,
that is at ionic strengths greater than 50 mM. One criterion
for a blocked state is a lag in binding of S1 to regulated actin
in the absence of Ca2⫹ when S1 is in excess over actin
(Trybus and Taylor, 1980). This lag in binding has been
interpreted as a delay caused by the transition from the
“blocked” state to the “closed” state of actin (McKillop and
Geeves, 1993). Binding studies used to argue for a blocked
state were done with S1 or S1-ADP, but the assumption was
made that the blocked state applied to the binding of S1ATP-like states also. This was contrary to earlier studies
that showed binding of S1-ATP-like states to regulated actin
at ionic strengths ⱖ50 mM both in solution (Chalovich and
Eisenberg, 1982; El-Saleh and Potter, 1985) and in single
muscle fibers (Kraft et al., 1995). Furthermore the high level
of regulation of ATPase activity at low ionic strength (Chalovich and Eisenberg, 1982) is inconsistent with the loss of
a major contributing factor to regulation under those conditions. More recently there has been recognition that S1ATP-like states may be different from the low affinity
intermediate observed in experiments done with rigor S1
(Holmes, 1995; Geeves and Conibear, 1995). However, this
has not been tested systematically.
To establish the conditions necessary to produce a
blocked state we examined the rate of binding of rigor S1
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and S1-ADP to regulated actin over a range of ionic strength
conditions. We did not observe a discrete change in the lag
as might be expected if a blocked state occurred only above
50 mM ionic strength. Rather, the lag duration increased
continuously as the ionic strength was increased. The first
evidence of what may be called a lag appeared by 30 mM
ionic strength in the presence of ADP. The lag duration
increased above 30 mM but the greatest change in the lag
occurred when the ionic strength was increased above the
physiological value (⬇150 mM).
The change in lag duration was most likely the result of
a change in the regulated actin filament. This change could
be in the number of bound molecules of S1 required to
stabilize the active state, the rate of transition from the
inactive to the active state, or the equilibrium constant
between the two states. Preliminary simulations suggest that
changes in the affinity or rate of association of S1 to actin
have little effect on the lag. Any explanation of the reason
for the ionic strength dependence of the lag will be model
dependent. Chen et al. (2001) have shown that the Hill
model (Hill et al., 1980, 1981) is able to simulate the lag in
binding and the effect of Ca2⫹ on the rate of S1 binding
without incorporating a blocked state. A detailed analysis of
the lag by different models will be presented elsewhere. At
present it is sufficient to note that what may be called a
blocked state exists at ionic strengths greater than 30 mM.
To determine the existence of a blocked state that is
refractory to the binding of the nonactivating S1 to regulated actin we measured the binding at several conditions.
Binding was measured at increasing concentrations of
PDM-S1-ATP so that high levels of saturation could be
achieved allowing the examination of blocking of a fraction
of the total binding sties. The data were well described by a
simple hyperbolic binding mechanism at 25, 60, and 100
mM ionic strength. In no case could the data be fitted with
a model in which 80% of the S1 binding sites of actin were
stably blocked in the absence of Ca2⫹. This can be seen
even in the case of the highly scattered binding at 100 mM
ionic strength (Fig. 6 C, dotted curve).
If, on the other hand, there were a rapid equilibrium
between blocked and nonblocked states then the binding
constants would change in a discontinuous way to compensate for the loss of available sites on actin. Association
constants calculated using a simple binding model with no
blocked state are shown as solid circles in Fig. 8. The ionic
strength dependence of these constants is the same as for the
binding to actin in the absence of regulatory proteins where
no blocked state is possible. This too shows that the binding
of nonactivating S1 to regulated actin is not blocked. Another point to consider is that at 60 mM ionic strength,
where blocking is supposed to occur, the affinity of binding
of PDM-S1-ATP to actin is the same in the presence and
absence of Ca2⫹ (Fig. 6) even though the population of the
blocked state is supposed to be very small in the presence of
Ca2⫹. Note that we have restricted ourselves to a discussion
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FIGURE 8 Ionic strength dependence of nonactivating S1 binding to
actin. The constants for the binding of high concentrations of PDMS1 to
regulated actin (solid circles) were calculated from Eq. 3 assuming that
virtually none of the actin was in a blocked state (from Fig. 6). These data
are compared with results of single point measurements of PDMS1-ATP
binding to actin with actin in large excess over pPDM-S1-ATP so that very
little of the actin contains bound PDM-S1-ATP (open circles). The
diamonds represent the binding of pPDM-S1-ATP to actin in the absence
of troponin-tropomyosin (Kirshenbaum et al., 1993). Also shown is the
binding of S1-ATP to actin with actin in large excess over S1 (squares)
(taken from Chalovich et al., 1983; Highsmith and Murphy, 1992; Frisbie
et al., 1998). The triangles are for the binding of S1 to pure actin in the
presence of saturating AMP-PNP where S1 forms a nonactivating state
(Frisbie et al., 1998).

of myosin S1 because this fragment has been used for the
generation of both the Hill model and the McKillop and
Geeves model.
It was possible to simulate individual binding curves with
a model in which blocked and nonblocked states were in
rapid equilibrium. That is, theoretical curves for Fig. 6 were
similar for rapid equilibrium models whether we assumed
that either 0% or 80% of the actin sites were blocked (Eq.
3). However, the results of a rapid equilibrium blocked
model were unreasonable. The calculated binding constants
for the nonblocked states have to increase by a factor of 5 to
compensate for the effective lowering of the actin concentration caused by blocking. That is, in the absence of Ca2⫹,
the affinity of the nonblocked states for S1 is fivefold
greater than in the presence of Ca2⫹. Such behavior is
inconsistent with all current models of regulation.
Our data do not support the concept that regulation by
tropomyosin-troponin occurs primarily by blocking the
binding of all myosin states to actin. Nonactivating states of
S1 bind to regulated actin under conditions where the binding of activating states is inhibited or “blocked”. The transition from nonactivating “weak binding” states to activating “strong binding” states appears to be regulated. We
suggested earlier that this could occur either by inhibition of
the rate of phosphate release (Chalovich and Eisenberg,
1982) or by inhibiting the transition of actin from an inhibBiophysical Journal 83(2) 1039 –1049
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ited state to an active state (Hill et al., 1981). This topic was
reviewed in some detail earlier (Chalovich, 1992). Others
have suggested that the position of tropomyosin in relaxed
muscle might allow binding of an electrostatic “collision
complex” of myosin to actin but partially block the stronger
binding that involves electrostatic and hydrophobic interactions (Holmes, 1995; Geeves and Conibear, 1995). The
complex that we have described here and elsewhere does
not appear to be a collision complex (for details on the
S1-ATP state, see Chalovich, 1992). In the Hill model
S1-ATP and S1-ADP-Pi are discrete states. However, in
that model it is possible to incorporate a two-step binding of
activating-S1 to actin (electrostatic followed by electrostatic
and hydrophobic) to accommodate the details of both types
of interaction (Chen et al., 2001). Thus, for this reason and
others stated earlier, the Hill model remains a reasonable
framework for understanding regulation of striated muscle
contraction.
The role of tropomyosin in this striated muscle regulatory
system appears to be different from its role in conjunction
with smooth muscle caldesmon. In the case of actin-tropomyosin-caldesmon, it is the caldesmon that is responsible
for inhibition of the rate of binding of S1 to actin (Sen et al.,
2001). Furthermore, tropomyosin-troponin has a much
greater effect on the equilibrium binding of activating states
(i.e., S1-ADP and S1) than on nonactivating states, whereas
caldesmon has its greatest effect on the equilibrium binding
of nonactivating states (Chalovich et al., 1987). Tropomyosin may actually enhance the ability of caldesmon to
compete with activating S1 binding to actin (Chen and
Chalovich, 1992). These different functions of tropomyosin
may result from the different positions that tropomyosin
occupy on actin in the presence of caldesmon and in the
presence of troponin (Hodgkinson et al., 1997).

CONCLUSIONS
The data shown here are consistent with the Hill model
shown in simplified form in Fig. 7. The Hill model can also
simulate the cooperative equilibrium binding of S1 to actin
(Hill et al., 1980), the steady-state ATPase activity at both
high actin and high S1 conditions (Hill et al., 1981), the
relationship between the rate of force redevelopment, the
extent of activation of single muscle fibers (Brenner and
Chalovich, 1999), and also the lag in the rate of binding in
the absence of Ca2⫹ (Chen et al., 2001). In the Hill model
the primary function of the movement of tropomyosin is to
alter the ability of the actin filament to accelerate ATP
hydrolysis. That is, the real importance of the overlap between the inhibitory positions of tropomyosin on actin and
the strong binding or activating states of S1 may be that this
arrangement permits S1 to act as a switch, in addition to
Ca2⫹ to alter the activity of the actin filament.
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